Research News and Research

RSS

Pregnant breast cancer patients can receive chemotherapy without endangering baby health

Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).

26 Mar 2010

UHC/AACN Nurse Residency Program helps members achieve 4.4% turnover rate

The University HealthSystem Consortium, an alliance of 107 academic medical centers and 232 of their affiliated hospitals, announced today that the UHC/AACN Nurse Residency Program™ has helped members achieve an astounding 4.4% turnover rate among first-year nurses.

26 Mar 2010

Women continue to be main caregivers for minors, elderly, disabled and sick

The main conclusion of this research is that in spite of the noteworthy advances of recent decades, women continue to be the main caregivers for minors as well as for the elderly, disabled or the sick. In general, traditional family care is increasingly more unsustainable, chiefly because of women's incorporation into the workplace and the decrease in the number of housewives, the increase of the aging population, and the increasing age of the caregivers themselves.

26 Mar 2010

Tumors mimic lymphoid tissue and alter host's immune response

A new mechanism explaining how tumors escape the body's natural immune surveillance has recently been discovered at EPFL (Ecole Polytechnique Fédérale de Lausanne) in Switzerland. The study shows how tumors can create a tolerant microenviroment and avoid attack by the immune system by mimicking key features of lymph nodes.

26 Mar 2010

Working of master regulator protein phosphatase 1

Protein phosphorylation is a process by which proteins are flipped from one activation state to another. It is a crucial function for most living beings, since phosphorylation controls nearly every cellular process, including metabolism, gene transcription, cell-cycle progression, cytoskeletal rearrangement and cell movement.

26 Mar 2010

Sirolimus-based immunosuppression improves survivals after transplantation for HCC

A recent study found that sirolimus-based immunosuppression following liver transplantation in patients with non-resectable hepatocellular carcinoma (liver cancer) significantly increases survival rates for this patient population.

26 Mar 2010

Researchers identify link between socioeconomic status and common disease symptoms

Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.

26 Mar 2010

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients.

26 Mar 2010

Modified protein plays a key role in memory processes

How do we process thoughts and store memories? A team of researchers headed by Dr. Nahum Sonenberg of McGill's Department of Biochemistry and Goodman Cancer Centre has discovered that brains in mammals modify a particular protein in a unique way, which alters the protein's normal function.

26 Mar 2010

Common beliefs on the spread of sexually transmitted diseases may not apply to HPV: Study

A small new study suggests that some common beliefs about the spread of sexually transmitted diseases may not apply to human papillomavirus, also known as HPV.

26 Mar 2010

New diagnostic test for early detection of Alzheimer's disease

A new test developed by Japanese scientists may revolutionize how and when physicians diagnose Alzheimer's disease.

26 Mar 2010

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors, prescribed drugs that inhibit the effect of an important enzyme.

26 Mar 2010

Pregnancy safe for breast cancer survivors, says study

Women who have been treated for breast cancer can choose to become pregnant and have babies, without fears that pregnancy could put them at higher risk of dying from their cancer, according to a major, new study.

26 Mar 2010

NYU researchers identify novel therapy for rheumatoid arthritis

By enhancing the activity of immune cells that protect against runaway inflammation, researchers at NYU Langone Medical Center may have found a novel therapy for rheumatoid arthritis and other autoimmune diseases.

26 Mar 2010

Work addiction is a psychosocial problem

Researchers from the Jaume I University have proven the usefulness of DUWAS, a new scale for measuring addiction to work, a disorder that affects around 12% of all working people in Spain.

26 Mar 2010

$UCSF study: Unusual femur fractures low in patients with osteoporosis$

UCSF study: Unusual femur fractures low in patients with osteoporosis

The occurrence of an unusual type of fracture of the femur, or the thigh bone, is very low in patients with osteoporosis, including those treated with the drug family known as bisphosphonates, according to a new study led by a team of UCSF epidemiologists.

26 Mar 2010

FIMM to launch cell microarray screening research program utilizing Aushon 2470 Arrayer technology

Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis announced today that the Institute for Molecular Medicine Finland will launch a cell microarray screening research program utilizing the Aushon 2470 Arrayer technology.

26 Mar 2010

Study: Cell-based strategy for treating neurodegenerative diseases

UCSF scientists have used a novel cell-based strategy to treat motor symptoms in rats with a disease designed to mimic Parkinson's disease.

26 Mar 2010

Data on Argos Therapeutics' Phase 2a AGS-004 immunotherapy trial presented at Banff HIV Vaccines meeting

Argos Therapeutics today announced the presentation of data from the Phase 2a trial of AGS-004, providing information on rebound viral genetic diversity in HIV patients treated with the personalized immunotherapy following antiretroviral therapy (ART) interruption. The data were discussed in a poster session at the Keystone Symposia Global Health Series HIV Vaccines meeting, held March 21-26, 2010 in Banff, Canada.

26 Mar 2010

New technique to deliver cancer treatments directly to certain tumours

Research conducted and patented by Dr Mark Howard at the University of Kent's School of Biosciences has led to the development of a new technique that will deliver cancer treatments directly to certain tumours.

26 Mar 2010

Research News and Research

Pregnant breast cancer patients can receive chemotherapy without endangering baby health

UHC/AACN Nurse Residency Program helps members achieve 4.4% turnover rate

Women continue to be main caregivers for minors, elderly, disabled and sick

Tumors mimic lymphoid tissue and alter host's immune response

Working of master regulator protein phosphatase 1

Sirolimus-based immunosuppression improves survivals after transplantation for HCC

Researchers identify link between socioeconomic status and common disease symptoms

Muscular dystrophy: $1M grant for study of erectile dysfunction drugs in improving muscle blood flow

Modified protein plays a key role in memory processes

Common beliefs on the spread of sexually transmitted diseases may not apply to HPV: Study

New diagnostic test for early detection of Alzheimer's disease

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

Pregnancy safe for breast cancer survivors, says study

NYU researchers identify novel therapy for rheumatoid arthritis

Work addiction is a psychosocial problem

UCSF study: Unusual femur fractures low in patients with osteoporosis

FIMM to launch cell microarray screening research program utilizing Aushon 2470 Arrayer technology

Study: Cell-based strategy for treating neurodegenerative diseases

Data on Argos Therapeutics' Phase 2a AGS-004 immunotherapy trial presented at Banff HIV Vaccines meeting

New technique to deliver cancer treatments directly to certain tumours

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News